Related Experiment Video
Updated: Jul 16, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
Cancer vaccines
Paula M Muehlbauer1, Douglas J Schwartzentruber
1Clinical Center Nursing Department, National Institutes of Health, 9000 Rockville Pike, Bldg 10/Room 7D50/MSC 1664, Bethesda, MD 20892, USA.
Objective:
To provide a review of cancer vaccines, how they work, and the current state of the science underlying these treatments.
Data Sources:
Research studies, review articles, book chapters, personal communications.
Conclusion:
Vaccines have been studied in a variety of malignancies; however, melanoma has provided the best tumor model for vaccination. Clinical trials continue to investigate the optimal vaccine, route, and immunization schedule.
Implications For Nursing Practice:
Oncology nurses must grasp a widening array of therapeutic options for cancer patients. The educational needs of the patient will be better met through a thorough understanding of basic concepts of newer cancer therapies.
Insights
Cancer vaccines are an evolving treatment. While melanoma has shown promise as a model for cancer vaccination, ongoing clinical trials aim to optimize vaccine strategies for better patient outcomes.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Background:
- Cancer vaccines represent a rapidly advancing area of therapeutic oncology.
- Understanding the mechanisms and current status of these treatments is crucial for healthcare professionals.
Purpose of the Study:
- To review the fundamental principles of cancer vaccines.
- To outline the current scientific landscape of cancer vaccine development and application.
Main Methods:
- A comprehensive review of existing research studies.
- Inclusion of data from review articles, book chapters, and personal communications.
Main Results:
- Melanoma has emerged as a leading tumor model for cancer vaccine research.
- Vaccine efficacy is being explored across diverse malignancies.
Conclusions:
- Further clinical trials are essential to determine optimal vaccine types, delivery routes, and immunization schedules.
- Oncology nurses require a robust understanding of cancer vaccines to educate patients and manage evolving treatment options.
Related Concept Videos
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

